110 related articles for article (PubMed ID: 18088228)
1. Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies.
Roukos DH
Expert Rev Mol Diagn; 2008 Jan; 8(1):29-39. PubMed ID: 18088228
[TBL] [Abstract][Full Text] [Related]
2. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
Roukos DH
Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.
Santacroce L; Cagiano R; Del Prete R; Bottalico L; Sabatini R; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Losacco T
Clin Ter; 2008; 159(6):457-62. PubMed ID: 19169609
[TBL] [Abstract][Full Text] [Related]
4. Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancer.
Jiang Y; Kimchi ET; Staveley-O'Carroll KF; Cheng H; Ajani JA
Cancer; 2009 Aug; 115(16):3609-17. PubMed ID: 19526592
[TBL] [Abstract][Full Text] [Related]
5. Proteomic identification of biomarkers related to Helicobacter pylori-associated gastroduodenal disease: challenges and opportunities.
Wu MS; Chow LP; Lin JT; Chiou SH
J Gastroenterol Hepatol; 2008 Nov; 23(11):1657-61. PubMed ID: 19120858
[TBL] [Abstract][Full Text] [Related]
6. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 expression and its association with angiogenesis, Helicobacter pylori, and clinicopathologic characteristics of gastric carcinoma.
Yamac D; Ayyildiz T; Coşkun U; Akyürek N; Dursun A; Seckin S; Koybasioglu F
Pathol Res Pract; 2008; 204(8):527-36. PubMed ID: 18462890
[TBL] [Abstract][Full Text] [Related]
8. Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery.
Roukos DH
Expert Rev Mol Diagn; 2008 Sep; 8(5):587-97. PubMed ID: 18785807
[TBL] [Abstract][Full Text] [Related]
9. [Molecular therapeutics in patients with cancer unresponsive to conventional treatments].
Valdespino-Gómez VM; Valdespino-Castillo VE
Gac Med Mex; 2008; 144(4):333-44. PubMed ID: 18942268
[TBL] [Abstract][Full Text] [Related]
10. Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.
Wagner AD; Moehler M
Curr Opin Oncol; 2009 Jul; 21(4):381-5. PubMed ID: 19412098
[TBL] [Abstract][Full Text] [Related]
11. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis.
Busuttil RA; Boussioutas A
J Gastroenterol Hepatol; 2009 Feb; 24(2):193-201. PubMed ID: 19215332
[TBL] [Abstract][Full Text] [Related]
12. Applications of genomic tools to colorectal cancer therapeutics.
Auman JT; McLeod HL
Curr Opin Mol Ther; 2008 Dec; 10(6):548-54. PubMed ID: 19051132
[TBL] [Abstract][Full Text] [Related]
13. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Helicobacter pylori and prevention of gastric cancer.
Cheung TK; Wong BC
J Dig Dis; 2008 Feb; 9(1):8-13. PubMed ID: 18251788
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up.
Kim N; Park RY; Cho SI; Lim SH; Lee KH; Lee W; Kang HM; Lee HS; Jung HC; Song IS
J Clin Gastroenterol; 2008; 42(5):448-54. PubMed ID: 18344895
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of therapeutic approaches to gastric cancer.
Wu K; Nie Y; Guo C; Chen Y; Ding J; Fan D
J Gastroenterol Hepatol; 2009 Jan; 24(1):37-41. PubMed ID: 19196394
[TBL] [Abstract][Full Text] [Related]
17. Predictive role of nuclear factor-kappaB activity in gastric cancer: a promising adjuvant approach with caffeic acid phenethyl ester.
Wu CS; Chen MF; Lee IL; Tung SY
J Clin Gastroenterol; 2007; 41(10):894-900. PubMed ID: 18090157
[TBL] [Abstract][Full Text] [Related]
18. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA
Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079
[TBL] [Abstract][Full Text] [Related]
19. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
20. Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori.
Sawaya M; Yoshimura T; Shimoyama T; Munakata A; Fukuda S
J Clin Gastroenterol; 2008 Apr; 42(4):351-5. PubMed ID: 18277906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
